نتایج جستجو برای: rev 1

تعداد نتایج: 2765708  

2017

101 Recording of Absences (Attendance) [1] [rev. Oct 1999] 102 Hours of Work [2] [rev. Oct 1999] 103 Vacation Leave [3] [rev. Aug 2004] 104 Sick Leave [4] [rev. Nov 1999] 105 Membership Fees [5] [rev. Oct 1999] 106 Termination [6] [rev. Oct 1999] 107 Acting Pay [7] [rev. Nov 1999] 108 Professional Development Reimbursement [8] [rev. Jul 2005] 109 Self-Funded Leave, see Policy 501Leave of Absenc...

2017

101 Recording of Absences (Attendance) [1] [rev. Oct 1999] 102 Hours of Work [2] [rev. Oct 1999] 103 Vacation Leave [3] [rev. Aug 2004] 104 Sick Leave [4] [rev. Nov 1999] 105 Membership Fees [5] [rev. Oct 1999] 106 Termination [6] [rev. Oct 1999] 107 Acting Pay [7] [rev. Nov 1999] 108 Professional Development Reimbursement [8] [rev. Jul 2005] 109 Self-Funded Leave, see Policy 501Leave of Absenc...

2016

101 Recording of Absences (Attendance) [1] [rev. Oct 1999] 102 Hours of Work [2] [rev. Oct 1999] 103 Vacation Leave [3] [rev. Aug 2004] 104 Sick Leave [4] [rev. Nov 1999] 105 Membership Fees [5] [rev. Oct 1999] 106 Termination [6] [rev. Oct 1999] 107 Acting Pay [7] [rev. Nov 1999] 108 Professional Development Reimbursement [8] [rev. Jul 2005] 109 Self-Funded Leave, see Policy 501Leave of Absenc...

2016

101 Recording of Absences (Attendance) [1] [rev. Oct 1999] 102 Hours of Work [2] [rev. Oct 1999] 103 Vacation Leave [3] [rev. Aug 2004] 104 Sick Leave [4] [rev. Nov 1999] 105 Membership Fees [5] [rev. Oct 1999] 106 Termination [6] [rev. Oct 1999] 107 Acting Pay [7] [rev. Nov 1999] 108 Professional Development Reimbursement [8] [rev. Jul 2005] 109 Self-Funded Leave, see Policy 501Leave of Absenc...

ژورنال: دامپزشکی 2015

کنترل و ریشه کنی بیماری بروسلوز در ایران مبتنی بر واکسیناسیون دام های حساس با  واکسن 1 Rev است. این واکسن با استفاده از محیط های کشت بروسلا آگار تجاری تولید می شود که به دلیل تحریم های اقتصادی، واردات این محیط کشت به سختی و با قیمت های بسیار گزاف امکان پذیر می باشد، لذا با توجه به سابقه تولید محیط گلیسرول دکستروزآگار در کشور و ثبت بین المللی آن، این مطالعه جهت بررسی امکان جاگزینی آن با محیط وار...

2013
Thomas Vercruysse Eline Boons Tom Venken Els Vanstreels Arnout Voet Jan Steyaert Marc De Maeyer Dirk Daelemans

HIV-1 Rev is the key protein in the nucleocytoplasmic export and expression of the late viral mRNAs. An important aspect for its function is its ability to multimerize on these mRNAs. We have recently identified a llama single-domain antibody (Nb190) as the first inhibitor targeting the Rev multimerization function in cells. This nanobody is a potent intracellular antibody that efficiently inhi...

Journal: :Journal of virology 1996
S Kubota L Duan R A Furuta M Hatanaka R J Pomerantz

Rev, a major regulatory protein of human immunodeficiency virus type 1, has been demonstrated to shuttle between the nucleus and cytoplasm of infected cells. The fate of the Rev protein in living cells was evaluated by pulse-chase experiments using a transient Rev expression system. Sixteen hours after chasing with unlabelled amino acids, 45% of the labelled Rev was still present, which clearly...

2017

101 Recording of Absences (Attendance) [1] [rev. Oct 1999] 102 Hours of Work [2] [rev. Oct 1999] 103 Vacation Leave [3] [rev. Aug 2004] 104 Sick Leave [4] [rev. Nov 1999] 105 Membership Fees [5] [rev. Oct 1999] 106 Termination [6] [rev. Oct 1999] 107 Acting Pay [7] [rev. Nov 1999] 108 Professional Development Reimbursement [8] [rev. Jul 2005] 109 Self-Funded Leave, see Policy 501Leave of Absenc...

2014
Ashok Chauhan

Astrocytes protect neurons, but also evoke proinflammatory responses to injury and viral infections, including HIV. There is a prevailing notion that HIV-1 Rev protein function in astrocytes is perturbed, leading to restricted viral replication. In earlier studies, our finding of restricted viral entry into astrocytes led us to investigate whether there are any intracellular restrictions, inclu...

2007
E. Katsavounidis

[8] The LIGO Collaboration, “Search for gravitational-wave bursts in LIGO data from the fourth science run”, arXiv:0704.0943 (submitted to Class Quant Grav) [7] F. Beauville et al., “Detailed comparison of LIGO and Virgo Inspiral Pipelines in Preparation for a Joint Search”, arXiv:gr-qc/0701027 (submitted to Class Quant Grav) [6] F. Beauville et al., “A comparison of methods for gravitational w...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید